INVEGA HAFYERA Trademark

Trademark Overview

On Wednesday, January 22, 2020, a trademark application was filed for INVEGA HAFYERA with the United States Patent and Trademark Office. The USPTO has given the INVEGA HAFYERA trademark a serial number of 88768753. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by JOHNSON & JOHNSON. The INVEGA HAFYERA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the treatment of central nervous system diseases
invega hafyera

General Information

Serial Number88768753
Word MarkINVEGA HAFYERA
Filing DateWednesday, January 22, 2020
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6815567
Registration DateTuesday, August 9, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the treatment of central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 26, 2020
Primary Code005
First Use Anywhere DateMonday, October 4, 2021
First Use In Commerce DateMonday, October 4, 2021

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Friday, July 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 15, 2022USE AMENDMENT FILED
Thursday, July 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 15, 2022TEAS STATEMENT OF USE RECEIVED
Friday, January 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2022SOU EXTENSION 3 GRANTED
Wednesday, January 5, 2022SOU EXTENSION 3 FILED
Wednesday, January 5, 2022TEAS EXTENSION RECEIVED
Friday, May 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021SOU EXTENSION 2 GRANTED
Wednesday, May 12, 2021SOU EXTENSION 2 FILED
Wednesday, May 12, 2021TEAS EXTENSION RECEIVED
Saturday, December 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020SOU EXTENSION 1 GRANTED
Thursday, December 17, 2020SOU EXTENSION 1 FILED
Thursday, December 17, 2020TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 6, 2020ASSIGNED TO EXAMINER
Sunday, January 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 25, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

hafyera invega nervous system diseases central treatment pharmaceutical preparations human